The eClinical solutions market was valued at USD 11.43 billion in 2024, and is projected to grow to USD 30.83 billion by 2032, representing a Compound Annual Growth Rate (CAGR) of 13.2% during the forecast period. This growth is primarily driven by the increasing number and complexity of clinical trials, the rising adoption of cloud-based solutions, the expansion of biotech firms, and greater emphasis on patient-centric trial models.